| Literature DB >> 30445805 |
Do-Hyoung Kim1, Kyou-Hoon Han2.
Abstract
Intrinsically disordered proteins (IDPs) are unorthodox proteins that do not form three-dimensional structures under non-denaturing conditions, but perform important biological functions. In addition, IDPs are associated with many critical diseases including cancers, neurodegenerative diseases, and viral diseases. Due to the generic name of "unstructured" proteins used for IDPs in the early days, the notion that IDPs would be completely unstructured down to the level of secondary structures has prevailed for a long time. During the last two decades, ample evidence has been accumulated showing that IDPs in their target-free state are pre-populated with transient secondary structures critical for target binding. Nevertheless, such a message did not seem to have reached with sufficient clarity to the IDP or protein science community largely because similar but different expressions were used to denote the fundamentally same phenomenon of presence of such transient secondary structures, which is not surprising for a quickly evolving field. Here, we summarize the critical roles that these transient secondary structures play for diverse functions of IDPs by describing how various expressions referring to transient secondary structures have been used in different contexts.Entities:
Keywords: intrinsically disordered protein (IDP); pre-populated; pre-structured; transient secondary structure
Mesh:
Substances:
Year: 2018 PMID: 30445805 PMCID: PMC6275026 DOI: 10.3390/ijms19113614
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
NMR parameters used for delineating transient secondary structures or pre-structured motifs in mostly unstructured IDPs/IDRs.
| CSI/SSP | Interproton | 15N-1 | T1 | T2 | 3JHNHα | Temp. Coeff. | HX Rate | Ref | |
|---|---|---|---|---|---|---|---|---|---|
| FlgM | O | O | O | O | 27 | ||||
| KID | O | O | 18 | ||||||
| GBD/CRIB | O | O | O | 28 | |||||
| HIV-1 Nef | O | O | O | O | 29 | ||||
| Synaptobrevin-2 | O | 36 | |||||||
| APPC | O | O | O | 38 | |||||
| p53 TAD | O | O | O | O | O | O | O | O | 23 |
| RPS4 | O | O | O | O | 39 | ||||
| α-Synuclein | O | 25 | |||||||
| Securin | O | O | O | O | 55 | ||||
| VP16 TAD | O | O | 54 | ||||||
| VP16 TAD | O | O | O | O | O | O | 52 | ||
| preS1 of HBV | O | O | O | O | O | O | O | 41 | |
| Sml1 | O | 24 | |||||||
| dSLBP | O | O | O | O | 30 | ||||
| NTAIL Sendai V. | O | 31 | |||||||
| nucleoprotein | |||||||||
| Sic1 | O | O | O | 51 | |||||
| c-Myc | O | O | O | O | O | 48 | |||
| ExsE | O | O | O | O | 33 | ||||
| MAP2c | O | 53 | |||||||
| NS5A HCV | O | O | 32 | ||||||
| NS5A HCV | O | O | O | O | 49 | ||||
| 4EBP2 | O | O | O | 56 | |||||
| 4EBP1 | O | O | O | O | O | O | 46 | ||
| ICIn | O | 35 | |||||||
| TAU | O | O | O | 7 | |||||
| E7 HPV | O | O | O | O | O | 42 | |||
| SUSP4 | O | O | O | O | O | O | 44 | ||
| hGR tau1c | O | O | O | O | O | O | 45 | ||
| Huntingtin | O | O | 57 |
Figure 1A schematic diagram showing two possible mechanisms of IDP-target binding. (Left) a target-free fragment of an IDP or a long (> 40 residues) IDR exists in a conformational ensemble where a completely unstructured state (bottom) is in equilibrium with a pre-populated state having transient helices of slightly different helical lengths (top). The fraction of the pre-populated state has been shown to vary from one IDP to another (10 ~ 70%) [5]. The three pre-structured helices with slightly different helical lengths were experimentally observed by Flexible-Meccano calculations using residual dipolar couplings in the case of the NTAIL of Sendai virus nucleoprotein [31] and 4EBP1 [46]. (Right) a transient pre-structured helix seen in the target-unbound state becomes a stable helix upon target binding, which was observed in the case of p53TAD/mdm2 [23,64], KID/KIX [16,18], and 4EBP1/4EBP2 with eIF4E [46,56,65]. A peptide with a sequence of the pre-structured helix in p53TAD or in 4EBP1 is an inhibitor of mdm2 or eIF4E, which provides a basis for anti-cancer peptide therapeutics design. (Middle) two potential encounter complexes (EC). The top EC would be formed by a conformational selection (CS) process of a PreSMo by a target while the bottom EC produced in an induced fit (IF) mechanism. The top CS path would be more favorable in terms of entropy than the bottom path since the bottom EC would have to face a larger entropic penalty to form a stable helix during or upon target binding.